Skip to content
Company Analysis

agilon health, inc. AGL

A comprehensive view of key metrics, scores, and financial health for agilon health, inc.

Overview of agilon health, inc.

AGL NYQ
Healthcare Medical Care Facilities Framework: General Corporate Small Cap
agilon health, inc. (AGL), is a Small Cap company, in the Medical Care Facilities industry, last closed at $99.14, about 535.8% undervalued vs fair value, +5090.6% 1Y return, ranked 793/1145 in sector.
Metrics Rev Growth -2.1% ROE -131.0% Gross Margin -2.7%
USD 99.14
0.72%
(Delayed)
• Vol 90d: 531.7%
52-Week Range
Market Cap
$1.87B
Enterprise Value
$1.76B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Fair
Health
Fair
Efficiency
Weak
Valuation
Weak
Growth
Fair
Profitability
Fair
Health
Fair
Efficiency
Weak
Valuation
Weak
Completeness: 82%
Confidence: 85%
Updated: Jul 5
Top Beats

Quick Facts

Website https://www.agilonhealth.com
HQ Westerville, OH
Employees 1,076
Fiscal year Dec 31

Next Events

Earnings Aug 3 Estimated

Fair Value Snapshot

Bear Base Bull
$552
$630
$716
Current: $99.14 +536% vs base

Engine Room Money Flow™

Small Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$5.9B
-2.1%%
Gross Profit
$-160.0M
-3405.5%%
Operating Income
$-427.2M
-48%%
Net Income
$-391.3M
-50.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio FY2025
38.0%

Operating Cash Flow / Net Income

FCF / Net Income - not meaningful while net income is negative (a near-100% ratio here only reflects cash burn tracking accounting losses, not earnings quality)

Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating agilon health, inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
25
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
24
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 88% Coverage
Trade-Off Triangle Visualization A ternary plot showing AGL's balance between Growth (46.1%), Profitability (18.4%), and Safety (35.5%). Growth 46% Safety 36% Profitability 18%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

49th percentile vs peers
49
Key Signals
Revenue CAGR 3Y 35.4% 92p Rev Growth YoY -2.1% 30p EPS Growth YoY -49.3% 23p
Strengths
  • Revenue CAGR 3Y in top 20% of peers (35.4%, 92th percentile)
  • Strong liquidity position vs peers
Risks

No significant risks identified for this axis.

Profitability

19th percentile vs peers
20
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

37th percentile vs peers
38
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for agilon health, inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$630.32
- - -
+535.8% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000